Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers (NCT06189638) | Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. | 2024-01-30 |
Track Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.